Winnetka, CA, United States of America

Felix M Solamo

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2016.


% Patents Active = 100.0


 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Felix M. Solamo: Innovator in Bioreactor Technology

Introduction

Felix M. Solamo is a notable inventor based in Winnetka, CA (US). He has made significant contributions to the field of biotechnology, particularly in the treatment of cell culture media for bioreactors. His innovative approach utilizes advanced methods that enhance the efficiency and effectiveness of bioprocessing.

Latest Patents

Felix holds a patent for "Methods of treating cell culture media for use in a bioreactor." This invention provides methods for treating cell culture media using ultraviolet C (UVC) light and filtration. This technology is crucial for improving the quality of cell cultures, which are essential in various biotechnological applications.

Career Highlights

Felix is currently employed at Amgen Inc., a leading biotechnology company known for its innovative therapies. His work at Amgen has allowed him to apply his expertise in bioprocessing and contribute to the development of cutting-edge biotechnological solutions.

Collaborations

Felix has collaborated with several professionals in his field, including Joe Zhou. These collaborations have fostered a productive environment for innovation and have led to advancements in bioreactor technology.

Conclusion

Felix M. Solamo's contributions to biotechnology, particularly through his patented methods for treating cell culture media, highlight his role as an innovator in the industry. His work at Amgen Inc. and collaborations with peers further emphasize his commitment to advancing biotechnological solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…